Interpretation on the update of 2022 WHO classification of neuroendocrine tumors
10.3760/cma.j.cn112151-20231030-00321
- VernacularTitle:2022版WHO神经内分泌肿瘤分类解读
- Author:
Xinxin MAO
1
;
Jie CHEN
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院病理科，北京 100730
- Keywords:
International classification of diseases;
Pathology;
Neuroendocrine tumors
- From:
Chinese Journal of Pathology
2024;53(7):655-659
- CountryChina
- Language:Chinese
-
Abstract:
The 5th edition of the WHO Endocrine and Neuroendocrine Oncology Blue Book, released in 2022, contained some changes in the classification of neuroendocrine tumors. A brief summary of the main changes has been provided in this section. Mainly summarized as changes in naming, differentiation and classification of neuroendocrine tumors, and tumor grading systems related to anatomical locations, morphological characteristics of neuroendocrine tumors in different locations, auxiliary diagnostic and prognostic/therapeutic markers, differential diagnosis and diagnostic difficulties of neuroendocrine tumors.
